Independent Research Center for Clinical Trials in South LA County. Seller Financing AvailableThis profitable and established independent research has been conducting clinical trials since 2005. Site has conducted Phase II through Phase IV trials for a variety of pharmaceutical companies and clinical research organizations. Center is currently conducting trials for skin infections, arthritis and HIV and has a new skin infection trial set to start in the near future. Center has developed a strong reputation and good relationships with sponsors (including Pfizer, Cerexa, GlaxoSmithKline and Boehringer Ingleheim) so new trials are acquired without significant marketing.The seller owns two research centers and has decided to sell his most established and profitable one in order to help finance a real estate development project. The seller and site director will help the buyer obtain a sufficient number of new trials and will provide a generous training period to ensure a smooth transition and the continued success of the site. Training program would cover all aspects of the business, including pre-study qualifications, regulatory requirements, protocol start-up, investigator meetings, sponsor visits and study close out.Please note that in 2010, the FDA put a nationwide hold on many non-oncological independent research studies due to some fraudulent research centers. So 2010 revenues for most centers were abnormally less than 2009. Now that the FDA has lifted the ban, the seller is in the process and replenishing the study pipeline and will assist the buyer in getting a sufficient number of studies up and running to get this center back to performing at 2009 levels.This industry is expected to grow significantly over the next decade due to a growing reliance on outsourcing clinical trial work to subcontractors. This opportunity could be an ideal acquisition for a physician who would perform principal investigator duties. And depending on the buyer’s qualifications, the sellers are willing to provide seller financing.
Sales (2009): $953,000
Seller’s Discretionary Cash Flow (2009): $568,000
Disclaimer: The information above was furnished by the seller. Neither Broker nor its agents have verified the information and make no representations as to its accuracy or reliability.
We're sorry, this listing has been canceled.
Here are some similar listings that are still active:
Modern, Toxicology, Genomics Lab on the West Coast with Licenses in 49 States and Insurance Contracts. Turn-key CLIA, CAP Lab for Going National. This young lab is selling its entire, functioning, turn-key lab with state-of-the-art equipment for doing Genetics / Genomics, Toxicology, and routine chemistry testing. The Lab is moving to a much larger...
Or browse listings in the following categories: